Short-term intensive neoadjuvant chemotherapy improving 10-year survival for patients with stage II and operable stage III breast cancer

B Zhang, Y Cai, Q Zhang, Z Ying, S Jiang, H Xu… - Chinese Journal of …, 2004 - Springer
Objective To evaluate the 10-year curative effects of short-term intensive neoadjuvant
chemotherapy for operable breast cancer. Methods A total of 510 patients with stagell and …

Investigation of the effect of neoadjuvant chemotherapy on Stage II breast cancer

Y Song, D Wang - Chinese Journal of Clinical Oncology, 2007 - Springer
Objective To investigate the effect of neoadjuvant chemotherapy in treatment of Stage II
breast cancer. Methods The data from 113 patients with breast cancer of the same …

Neoadjuvant chemotherapy in patients with stages Ⅱ and Ⅲ breast cancer

Z Yuan, X Qu, Z Zhang, Y Wang - Chinese Medical Journal, 2009 - mednexus.org
Background Neoadjuvant chemotherapy has been used as a primary treatment for locally
advanced or inflammatory breast cancer, and recently extended to operable breast cancer …

Clinical Analysis on Neoadjuvant Chemotherapy of Advanced Breast Cancer

H LI, C Niao, X HE - Chinese Journal of Bases and Clinics in …, 2004 - pesquisa.bvsalud.org
Objective To study the long-term effect of neoadjuvant chemotherapy on advanced breast
cancer. Methods The CAF neoadjuvant chemotherapy [CTX 500 mg/m2 (1st day, 8th day), 5 …

Effect of neoadjuvant chemotherapy for stages Ⅱ and Ⅲ A breast cancer

S Qin, Z Zhang, X QU, J LI, Y Wang… - … Journal of Surgery, 2012 - pesquisa.bvsalud.org
ObjectiveTo evaluate the therapeutic value of neoadjuvant chemotherapy for patients with
stages Ⅱ and ⅢA (Only T3N1M0) breast cancer, and assess the relationship of the tumor …

Long-term results of preoperative chemotherapy for operable breast Cancer

B Zhang, Y Cai, Q Zhang - Zhonghua Zhong liu za zhi [Chinese …, 1997 - europepmc.org
Methods Patients were divided into preoperative chemotherapy group (group A, 253 cases)
and postoperative adjuvant chemotherapy group (group B, 284 cases). The group A patients …

Evaluation of two different regimens as neoadjuvant chemotherapy for breast cancer

D Yang, F Tong, Y Cao, P Liu, B Zhou… - Zhonghua Zhong liu …, 2002 - europepmc.org
Objective To compare the efficacy and toxicity of two different regimens as neoadjuvant
chemotherapy for breast cancer. Methods Forty-eight patients with stage II, III breast cancer …

Application of neoadjuvant chemotherapy for operable breast cancer

L Zheng, HY Gao, XL Zhang - Nan Fang yi ke da xue xue bao …, 2009 - europepmc.org
Objective To investigate the clinical value of neoadjuvant chemotherapy in the treatment of
operable breast cancer. Methods A total of 120 patients with pathologically proven operable …

Neo-adjuvant chemotherapy for breast cancer

J Shi, G Fang, Y Sheng - Zhonghua Zhong liu za zhi [Chinese …, 2001 - europepmc.org
OBJECTIVE: To study the value and indications of a neo-adjuvant chemotherapy for breast
cancers. METHODS: Forty-three breast cancer patients were given the NF neo-adjuvant …

Factors related with pathological complete response of neoadjuvant chemotherapy in primary breast cancer

YJ Cheng, JM Ye, L Xu, JX Zhao… - Zhonghua wai ke za zhi …, 2013 - europepmc.org
Objective To assess the effect of neoadjuvant chemotherapy and the factors related with
pathological complete response (pCR) of neoadjuvant chemotherapy in breast cancer …